Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Launched by DANA-FARBER CANCER INSTITUTE · Jun 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called DREAMS, is focused on helping children aged 9 to 17 who are undergoing stem cell transplants at Boston Children's Hospital. These young patients often face sleep problems during their stay in the hospital, which can make their recovery more difficult. The study aims to create a better sleeping environment for these children by providing them and their families with helpful tools and information designed to improve sleep and overall well-being while they are hospitalized.
To participate in this trial, children must be scheduled for a stem cell transplant at the hospital and have a parent or guardian who speaks English. The trial is currently looking for participants, and those who join will receive a special kit that includes resources to support better sleep during their hospital stay. This study is an important step in understanding how we can help young patients feel more comfortable and rested during a challenging time in their lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged 9-17 years.
- • Patient scheduled to receive a stem cell transplant at Boston Children's Hospital.
- • English speaking child and primary caregiver (parent/guardian).
- Exclusion Criteria:
- • -Primary team declines permission to approach.
About Dana Farber Cancer Institute
The Dana-Farber Cancer Institute is a premier cancer research and treatment institution located in Boston, Massachusetts. Renowned for its commitment to advancing cancer care through innovative research, the institute integrates cutting-edge clinical trials with a multidisciplinary approach to patient care. With a focus on translating scientific discoveries into effective therapies, Dana-Farber collaborates with a network of leading researchers and healthcare professionals to improve outcomes for patients with cancer. The institute’s dedication to education, advocacy, and community engagement further underscores its mission to eradicate cancer and enhance the quality of life for those affected by the disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Eric Zhou, PhD
Principal Investigator
Dana-Farber Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported